The COVID-19 pandemic has underscored the importance of understanding the various risk factors that can make certain populations more vulnerable to severe illness. Recent studies suggest that ...

RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the Phase 3 MOVe-NOW clinical trial to evaluate ...

The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a ...

Pregnant patients are less likely to receive antiviral treatment for COVID than for influenza despite guideline ...

The COVID-19 pandemic began five years ago, seemingly all at once. Treatments quickly became available, primarily because of federally funded basic research. (Photo by John Paraskevas/Newsday RM vis ...

A University of Missouri professor is among those who have successfully identified new early-stage molecules that could be used to combat future coronaviruses. Dr. Dimitri Kireev, a computational ...

OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) delivered a late-breaking scientific oral ...

As the Democratic Republic of Congo works to contain a new Ebola outbreak, the world is reminded that viral threats can re-emerge swiftly and unpredictably. The progress in managing this resurgence ...

Alyssa McDaniel, a 374th Medical Group COVID-19 Response Team member, uses a cotton swab to conduct a pre-travel rapid antigen test on a young patient at Yokota Air Base, Japan, March 22, 2022. (U.S.

SHELTON, CT / ACCESSWIRE / September 26, 2024 / NanoViricides, Inc. (NYSE American.:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that ...